智通财经网·2025-08-15 10:55Core Insights - UBS Group reported a total market value of approximately $580 billion in U.S. equities for Q2 2025, reflecting a 7% increase from the previous quarter's $540 billion [1][2] - The firm added 1,084 new stocks, increased holdings in 4,403 stocks, reduced holdings in 4,324 stocks, and completely sold out of 1,055 stocks during the quarter [1][2] - The top ten holdings accounted for about 14.79% of UBS's total market value in Q2 [1][2] Holdings Adjustments - UBS exhibited a cautious approach towards technology stocks, particularly in light of the AI-driven market surge, opting to take profits from major tech companies [3][5] - Microsoft became UBS's largest holding, with approximately 31.6 million shares valued at about $15.7 billion, representing 2.72% of the portfolio, despite a slight decrease of 3.95% in shares held [3][5] - NVIDIA ranked second with around 96.2 million shares valued at approximately $15.2 billion, accounting for 2.63% of the portfolio, down by 5.16% [3][5] - Apple was the third-largest holding, with about 54.1 million shares valued at around $11.1 billion, making up 1.92% of the portfolio, reflecting a 10.86% decrease [3][5] Sector Focus - The fourth-largest holding was Amazon, with approximately 35.9 million shares valued at about $7.9 billion, representing 1.36% of the portfolio, down by 4.52% [4][5] - Broadcom was fifth, holding about 25.5 million shares valued at approximately $7 billion, accounting for 1.22% of the portfolio, down by 7.53% [4][5] - The sixth to tenth largest holdings included Meta, SPY ETF, JPMorgan Chase, QQQ put options, and Google, all reflecting a trend of reduced positions in major tech stocks [4][5] Strategic Moves - UBS's strategy in Q2 involved significant profit-taking from tech giants while increasing protective positions in the Nasdaq 100 index, indicating a defensive stance against potential market corrections [5][6] - The top five purchases included QQQ put options, NVIDIA put options, SPY call options, Netflix, and Alcon call options, while the top five sales included SPY put options, Apple, UnitedHealth, SPY ETF, and UBS stock [6][7][8]